Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
UCSF-SCOR
Introduction
Official Title
Official Title
University of California San Francisco (UCSF) Arteriosclerosis Specialized Center of Research (SCOR) Intervention Trial
Objective
Objective
The objective of this study is to assess the effect of the decrease in low-density lipoprotein (LDL) by diet and drug combinations on the regression of coronary lesions.
Study Description
Study Description
| Study Design | |
| Allocation | Randomized |
| Masking | Open label |
| Endpoint | Mean variation in percent area stenosis |
| Study Details | |
| Condition | Familial Hypercholesterolemia |
| Study Arms | Niacin plus colestipol +/- lovastatin (+ diet) Diet alone |
| Population Size | 72 |
Outcomes
Outcomes
Primary Outcome
Within patient mean variation in percent area stenosis
Publications
Publications
The decrease in LDL among patients with familial hypercholesterolemia may lead to the regression of atherosclerotic lesions in the coronary arteries.[1]
References
References
- ↑ Kane JP, Malloy MJ, Ports TA, Phillips NR, Diehl JC, Havel RJ (1990). “Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens”. JAMA. 264 (23): 3007–12. PMID 2243428.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]